• Save
Teaser for report - Drug Research Scenario in India
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Teaser for report - Drug Research Scenario in India

on

  • 5,583 views

The research report of Aagami - ‘Drug Research Scenario in India’ – reveals how and what Indian companies are doing in the area of drug research and details out which companies are most active ...

The research report of Aagami - ‘Drug Research Scenario in India’ – reveals how and what Indian companies are doing in the area of drug research and details out which companies are most active in drug research activities and allied services

A must read for global companies who wish to collaborate with Indian companies

Statistics

Views

Total Views
5,583
Views on SlideShare
1,304
Embed Views
4,279

Actions

Likes
0
Downloads
1
Comments
0

8 Embeds 4,279

http://www.aagami.com 3580
http://aagami.com 691
http://webcache.googleusercontent.com 2
https://www.google.co.in 2
http://www.linkedin.com 1
http://honyaku.yahoofs.jp 1
http://131.253.14.66 1
http://www.google.com 1
More...

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Teaser for report - Drug Research Scenario in India Presentation Transcript

  • 1. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 1 Research Report on Drug Research Scenario in India INTRODUCTION Common perception about Indian Pharma companies is that they are good in generics and that drug research activities are less in India. Contrarian to popular belief, it was in the late 1990’s, that Indian Pharma companies started in-house drug discovery activities, aiming at developing the country’s first home-made drug. Today, there are many Indian companies involved in drug discovery, research and allied services. Even Government is lending help and supporting research activities in a big way through IP Protection laws and Public Private Partnerships in this space. New Drug Discovery and allied services has gained strong foothold in India. India is today one of the most sought after destinations for collaboration in Drug Research The research report of Aagami - ‘Drug Research Scenario in India’ – reveals how and what Indian companies are doing in the area of drug research and details out which companies are most active in the area of drug discovery, research activities and allied services A must read for global companies who wish to collaborate with Indian companies
  • 2. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 2 Research Scope and Structure  The Indian Pharma market prior to introduction of Patents Act of 1970  Presence of Multinational companies  Introduction of Patents Act of 1970  Impact of TRIPS w.e.f January 1995  Top Indian Pharma companies expenditure on R&D.  Deals: Partnering of MNCs with Indian companies for Collaborative research, R&D service agreement  Paradigm shift  India as destination for conducting clinical trials  MNC CRO in India  Indian companies has moved up value chain  Major therapeutic areas for drug research  Key therapy area for NCE of top Indian pharma companies  Therapeutic segment sales as of March 2012  Biosimilars  Major Platform considered/focused for NDDS  Repurposing/Re-profiling of Drugs  India’s IP regime  Public Private Partnership as a Indian Government initiatives  Benefits of Collaboration  Conclusion Overview: Historical perspective of Indain Pharma Market Current status in Drug Research Trends in Drug Discovery Government Initiatives Conclusion
  • 3. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 3 Table of Contents: 1. Introduction a. Objective of white paper b. Executive Summary 2. Acronyms Used 3. Overview: Historical perspective of Indian Pharma market a. Key Takeaway in Indian Pharma sector before and after enactment of Patents Act 1970 b. Table for three phases in Indian Pharmaceuticals. c. Impact of TRIPS on Indian Pharmaceutical companies 4. Scenario in India after 1970 patent Law which recognized process patents a. Example of Importance of India as the “Pharmacy for the developing world 5. Impact of World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPs) agreement on India 6. Current Status: In-Licensing & Out Licensing Deal (2002- 2011) a. Table for India’s top Pharmaceuticals company by sales and R&D expenditure b. Key examples of Drug research collaboration c. Table for R&D Out-Licensing deal. d. Table for Collaborative R&D agreement e. Table for Collaborative research done in India f. Table for Out-Licensing in India with global partners Contract Research (2006-2011) g. Table for R&D service agreement by Indian companies with MNC partner Mergers & Acquisitions (2004- 2012) h. Other R&D deal. i. Matrix for type of Alliances in India j. Top 10 Bioscience collaboration in 2012 for Drug research & allied services k. Paradigm Shift 7. Drug Portfolio pipeline of top Indian Pharma companies 8. Examples of Indian companies offering Drug Research services 9. India- hottest and favored destination for Clinical research outsourcing & conducting global trials in BRIC region 10. List of MNC having their Drug Discovery and service centers in India
  • 4. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 4 11. Instances for Indian companies have moved up the value curve 12. Trends in Drug Research in India a. Top key therapy areas in focus b. Table for Company & therapy areas c. Therapeutic segment sales as of March 2011 d. Biosimilars in India e. Top pharma companies & their biosimilar portfolio f. NDDS g. NDDS success stories & Market segment h. Repurposing of Drugs in India i. Initiatives for Repurposing of Drugs 13. India’s IP regimes & Government Initiatives 14. Benefits Of Collaborations 15. Conclusion Rest of Page is blank. SEE NEXT PAGE
  • 5. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 5 Key Highlights of the report: 1. The report gives whole scenario of Drug Research activities being carried out in India 2. Current market scenario in India 3. Top Indian Pharma companies with sales and R&D expenditures 4. Information on M&A, Joint research, CRO deals , In-Licensing, Out- Licensing deals took place 5. Top Indian Pharma companies with Drug Portfolios, patent pipeline, NCE pipelines 6. List of Indian companies offering Drug research services (CRO)and their operation and services portfolio 7. List of MNC CRO operating in India with their operation and services portfolio 8. India as a global destination for conducting global clinical trials & clinical outsourcing 9. Types of Alliances in India with MNCs. 10. India’s Top 10 Bioscience collaboration in 2012 indicating India’s expertise in Drug research arena. 11. Trends in Drug Research 12. Government Initiatives & India IP regime 13. Benefits of Collaborations 14. Facts and figures on India’s advantage for Drug research as compared to developed countries
  • 6. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 6 A Must Buy for: 1. Foreign companies who wish to collaborate with Indian companies 2. Existing Pharma/Biotech/ Drug Discovery Firms: To know their Indian counterpart Drug Development pipeline, trends, Information on leading pharma companies by sales & their R&D expenses. 3. New Pharma/Biotech/ Drug Discovery Firms: Information on In-Licensing & Out- Licensing scenario. Information on existing & new players in Drug Discovery 4. Research & Educational Institutes: To get an overview of India’s pharma & drug discovery scenario and current trends in Drug R&D 5. Consultants: To upgrade their knowledge in Indian pharma and drug R&D space. 6.
  • 7. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 7 Sample Snapshots of the Report: The Snapshots provided hereby is just a sneak peak of the whole report. The original document comprise of 45 slides. The report gives a complete scenario about the research activities being carried out in India. India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global pharmaceuticals and biotech firms in their research activities.
  • 8. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 8 Sample Snapshots of the Report: The Snapshots provided hereby is just a sneak peak of the whole report. The original document comprise of 45slides. The report gives a complete scenario about the research activities being carried out in India. India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global pharmaceuticals and biotech firms in their research activities.
  • 9. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 9 Sample Snapshots of the Report: Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 10. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 10 Sample Snapshots of the Report: Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 11. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 11 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 12. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 12 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 13. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 13 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 14. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 14 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 15. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 15 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 16. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 16 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 17. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 17 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 18. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 18 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 19. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 19 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 20. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 20 Contact us at godwyn@aagami.com or nidhi@aagami.com to have complete access to the full details of the report
  • 21. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 21 To place an order for this report, please get in touch with: Godwyn Francis - Business Development, Aagami, Inc. Email Id: godwyn@aagami.com Contact number: +91- 787-5106- 957 Aagami Inc, 2020 Calamos Court, Suite 209, Naperville IL 60563-2593 www.aagami.net The Snapshots provided in previous pages, is just a sneak peak of the whole report. The original document consists of 45 pages. The report gives a complete scenario about the research activities being carried out in India. India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global pharmaceuticals and biotech firms in their research activities.
  • 22. …………. Realizing Possibilities Copyright © 2013 Aagami, Inc – Teaser - Research Report: Drug Research Scenario in India Page 22